Dalal Jadayel

1.3k total citations · 1 hit paper
12 papers, 1.1k citations indexed

About

Dalal Jadayel is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dalal Jadayel has authored 12 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Genetics and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dalal Jadayel's work include Chronic Lymphocytic Leukemia Research (3 papers), Respiratory Support and Mechanisms (3 papers) and Acute Myeloid Leukemia Research (2 papers). Dalal Jadayel is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), Respiratory Support and Mechanisms (3 papers) and Acute Myeloid Leukemia Research (2 papers). Dalal Jadayel collaborates with scholars based in United Kingdom, United States and Denmark. Dalal Jadayel's co-authors include Martin J.S. Dyer, Rifat Hamoudi, Ming‐Qing Du, Huaizheng Peng, Amanda R. Perry, Helen P. Price, Peter G. Isaacson, Tony G. Willis, Tim Crook and Munah Abdul-Rauf and has published in prestigious journals such as Cell, Journal of Clinical Oncology and Clinical Cancer Research.

In The Last Decade

Dalal Jadayel

12 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bcl10 Is Involved in t(1;14)(p22;q32) of MALT B Cell Lymphoma and Mutated in Multiple Tumor Types

1999 521 citations Tony G. Willis, Dalal Jadayel et al. Cell profile →

Peers

Countries citing papers authored by Dalal Jadayel

Since Specialization

Citations

This map shows the geographic impact of Dalal Jadayel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dalal Jadayel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dalal Jadayel more than expected).

Fields of papers citing papers by Dalal Jadayel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dalal Jadayel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dalal Jadayel. The network helps show where Dalal Jadayel may publish in the future.

Co-authorship network of co-authors of Dalal Jadayel

This figure shows the co-authorship network connecting the top 25 collaborators of Dalal Jadayel. A scholar is included among the top collaborators of Dalal Jadayel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dalal Jadayel. Dalal Jadayel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Efficacy and Safety of Once-Daily QVA149 Compared With the Free Combination of Its Monocomponents: The BEACON Study 2014 ·CHEST Journal ·Ronald Dahl, Dalal Jadayel, Vijay Alagappan, Hungta Chen, Donald Banerji	2
2	Effect of QVA149 on lung volumes and exercise tolerance in COPD patients: The BRIGHT study 2014 ·Respiratory Medicine ·Kai-Michael Beeh, Stephanie Korn, Jutta Beier, Dalal Jadayel, Michelle Henley, Peter D’Andrea, Donald Banerji	97
3	Once-daily QVA149 provides the same efficacy as the free combination of its monocomponents indacaterol and glycopyrronium: The BEACON study 2013 ·European Respiratory Journal ·Ronald Dahl, Dalal Jadayel, Vijay Alagappan, Hungta Chen, Donald Banerji	2
4	Efficacy and safety of QVA149 compared to the concurrent administration of its monocomponents indacaterol and glycopyrronium: the BEACON study 2013 ·International Journal of COPD ·Ronald Dahl, Dalal Jadayel, Vijay K. T. Alagappan, Hungta Chen, (unknown)	65
5	A Phase I Pharmacokinetic and Pharmacodynamic Study of TKI258, an Oral, Multitargeted Receptor Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors 2008 ·Clinical Cancer Research ·Debashis Sarker, R. Molife, T. R. J. Evans, (unknown), Cheryl Marriott, (unknown), (unknown), Judith A. Fox, Carla Heise, Sharianne G. Louie, Natasha Aziz, (unknown), Glenn Michelson, Ian Judson, Dalal Jadayel, Edgar Braendle, Johann S. de Bono	117
6	Phase I and Pharmacodynamic Trial of the DNA Methyltransferase Inhibitor Decitabine and Carboplatin in Solid Tumors 2007 ·Journal of Clinical Oncology ·Kim Appleton, Helen Mackay, Ian Judson, Jane A. Plumb, Carol McCormick, Gordon Strathdee, (unknown), Sophie Barrett, (unknown), Dalal Jadayel, Adrian Tang, (unknown), (unknown), A Setanoians, Andreas G. Schätzlein, Chris Twelves, Stanley B. Kaye, Robert Brown	191
7	Incidence of MLL Rearrangement in Acute Myeloid Leukemia, and a CALM - AF10 Fusion in M4 Type Acute Myeloblastic Leukemia 2002 ·Leukemia & lymphoma ·Said Abdou, Dalal Jadayel, Toon Min, G. John Swansbury, Melissa Dainton, Osman Jafer, R Powles, Daniel Catovsky	11
8	Incidence of MLL Rearrangement in Acute Myeloid Leukemia, and a CALM - AF10 Fusion in M4 Type Acute Myeloblastic Leukemia 2002 ·Leukemia & lymphoma ·Said Abdou, Dalal Jadayel, Toon Min, G. John Swansbury, Melissa Dainton, Osman Jafer, R Powles, Daniel Catovsky	1
9	Cyclin D1 by flow cytometry as a useful tool in the diagnosis of B-cell malignancies 2001 ·Leukemia Research ·Manal O. Elnenaei, Dalal Jadayel, Estella Matutes, Ricardo Morilla, K Owusu-Ankomah, Shayne Atkinson, Ian Titley, (unknown), Daniel Catovsky	27
10	In Response to Fakruddin et al. and Apostolou et al 1999 ·Cell ·Martin J.S. Dyer, Helen P. Price, Dalal Jadayel, Milena Gasco, Amanda R. Perry, Rifat Hamoudi, Tony G. Willis, Huaizheng Peng, Ming‐Qing Du, Peter G. Isaacson	16
11	Bcl10 Is Involved in t(1;14)(p22;q32) of MALT B Cell Lymphoma and Mutated in Multiple Tumor Types breakdown → 1999 ·Cell ·Tony G. Willis, Dalal Jadayel, Ming‐Qing Du, Huaizheng Peng, Amanda R. Perry, Munah Abdul-Rauf, Helen P. Price, Loraine Karran, (unknown), Iwona Włodarska, Langxing Pan, Tim Crook, Rifat Hamoudi, Peter G. Isaacson, Martin J.S. Dyer	521
12	The BCL7 gene family: deletion of BCL7B in Williams syndrome 1998 ·Gene ·Dalal Jadayel, Lucy R. Osborne, Lionel Coignet, (unknown), Lap‐Chee Tsui, Stephen W. Scherer, Martin J.S. Dyer	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact